People: DexCom Inc (DXCM.O)

DXCM.O on Nasdaq

22.80USD
18 Jun 2013
Price Change (% chg)

$0.24 (+1.06%)
Prev Close
$22.56
Open
$22.66
Day's High
$22.97
Day's Low
$22.47
Volume
373,066
Avg. Vol
513,806
52-wk High
$22.97
52-wk Low
$10.65

Search Stocks

Skyler, Jay 

Brief Biography

Dr. Jay S. Skyler, M.D, MACP, is an Independent Director of DexCom Inc., since September 2002. Dr. Skyler is a Professor of Medicine, Pediatrics and Psychology and Deputy Director of the Diabetes Research Institute at the University of Miami in Florida, where he has been employed since 1976. Dr. Skyler also serves as Study Chairman for the National Institute of Diabetes & Digestive & Kidney Diseases Type 1 Diabetes TrialNet clinical trials network. Dr. Skyler also serves as a director of Amylin Pharmaceuticals, Inc., and served as a director of MiniMed, Inc. until its acquisition by Medtronic, Inc. in 2001. Dr. Skyler received a B.S. from Pennsylvania State University and an M.D. from Jefferson Medical College.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Excercisable -- --
Unexercisable -- --
Excercised -- --
Name Fiscal Year Total

Jonathan Lord

--

Kevin Sayer

2,046,680

Terrance Gregg

3,486,410

Jess Roper

664,714

Steven Pacelli

1,971,840

Andrew Balo

913,314
As Of 30 Dec 2011
Search Stocks